Edgewise Therapeutics begins Phase II Becker Muscular Dystrophy trial
The trial is expected to recruit around 66 subjects at up to 14 sites in the UK, US and the…

The trial is expected to recruit around 66 subjects at up to 14 sites in the UK, US and the…
Being carried out at the UMCG in the Netherlands, the trial will enrol healthy adult subjects aged between 18 and…
The trial will assess the immune system’s response to a 90µg booster dose of the AKS-452 vaccine in 600 subjects.
In the trial, treatment with 5mg and 10mg obicetrapib respectively led to a 42% and 51% decline in LDL-c.
Triall will leverage LTO Network's blockchain technology and infrastructure to anchor the research data.
Being carried out at University Medical Center Groningen in the Netherlands, the trial will have 52 participants.
The Phase III trial met the primary endpoint with efgartigimod showing improvement in the quality of life of patients.
AIM ImmunoTech has dosed the first healthy participants in a Phase I clinical study of its Ampligen drug as a…
Thank you for subscribing to Clinical Trials Arena